These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2890189)

  • 1. The effects of intermittent drug therapy on stereotypy and collateral behaviors of mentally retarded persons.
    Millichamp CJ; Singh NN
    Res Dev Disabil; 1987; 8(2):213-27. PubMed ID: 2890189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients--a pilot study.
    Aman MG; White AJ; Field C
    J Ment Defic Res; 1984 Dec; 28 ( Pt 4)():253-60. PubMed ID: 6396416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior.
    Aman MG; Singh NN
    Appl Res Ment Retard; 1982; 3(4):345-58. PubMed ID: 7168571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing behavior in mentally retarded residential populations.
    Deutsch SI
    Hosp Community Psychiatry; 1986 Mar; 37(3):221-2. PubMed ID: 2870016
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with Risperidone in the treatment of institutionalized mentally retarded patients, with special reference to treatment of aggressive states].
    Hal V; Fehér L
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):19-25. PubMed ID: 15125310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a screening procedure on pica and collateral behaviors.
    Singh NN; Winton AS
    J Behav Ther Exp Psychiatry; 1984 Mar; 15(1):59-65. PubMed ID: 6470159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is risperidone effective in reducing challenging behaviours in individuals with intellectual disabilities after 1 year or longer use? A placebo-controlled, randomised, double-blind discontinuation study.
    Ramerman L; de Kuijper G; Scheers T; Vink M; Vrijmoeth P; Hoekstra PJ
    J Intellect Disabil Res; 2019 May; 63(5):418-428. PubMed ID: 30609152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavior disorders in persons with mental retardation receiving antipsychotic medication.
    Ono Y
    Res Dev Disabil; 1998; 19(2):123-30. PubMed ID: 9547524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults.
    Janowsky DS; Barnhill LJ; Shetty M; Davis JM
    J Clin Psychopharmacol; 2005 Feb; 25(1):19-25. PubMed ID: 15643096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-injurious behavior and stereotypy in an institutionalized mentally retarded population.
    Barron JL; Sandman CA
    Appl Res Ment Retard; 1984; 5(4):499-511. PubMed ID: 6524940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents.
    Aman MG; White AJ
    J Autism Dev Disord; 1988 Sep; 18(3):355-66. PubMed ID: 3170454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: an open-label study.
    Spivak B; Mozes T; Mester R; Kodelik M; Weizman A
    J Child Adolesc Psychopharmacol; 2001; 11(3):279-84. PubMed ID: 11642477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of pica by overcorrection and physical restraint: a comparative analysis.
    Singh NN; Bakker LW
    J Autism Dev Disord; 1984 Sep; 14(3):331-41. PubMed ID: 6480550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
    Gualtieri CT; Lefler WH; Guimond M; Staye JI
    Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Willemsen-Swinkels SH; Buitelaar JK; Nijhof GJ; van England H
    Arch Gen Psychiatry; 1995 Sep; 52(9):766-73. PubMed ID: 7654128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thioridazine and visual screening on stereotypy and social behavior in individuals with mental retardation.
    Singh NN; Landrum TJ; Ellis CR; Donatelli LS
    Res Dev Disabil; 1993; 14(3):163-77. PubMed ID: 8316680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study by the behavioral observation for sterotypy in the exceptional children.
    Sakuma M
    Folia Psychiatr Neurol Jpn; 1975; 29(4):371-91. PubMed ID: 1241857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of zuclopenthixol in a double-blind placebo-controlled discontinuation study in adults with intellectual disabilities and aggressive behaviour.
    Schwarz V; Reis O; Glaser T; Thome J; Hiemke C; Haessler F
    Pharmacopsychiatry; 2014 Jan; 47(1):29-32. PubMed ID: 24307207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.